Skip to main content
. 2019 Jul 1;9:55–78. doi: 10.2147/DNND.S208815

Table 12.

Repository corticotropin injection

Study/N/Age/Location Intervention and treatment duration Summary of efficacy results
National Cooperative Clinical Trial
Henderson et al (1978)45
Rose et al (1969)46
Rose et al (1970)47
N=197
Age: NR
US
Intervention
RCI IM (n=103) vs placebo (n=94)
Treatment duration
14 days
Assessments
Within 24 hrs of treatment onset, days 7 and 14 of treatment, and days 7 and 14 following treatment
Proportion of patients improved DSS score (≥1 score change) at week 1 after treatment initiation:
RCI, 38%; placebo, 26%
DSS at week 2: RCI, 57%; placebo, 38%
DSS at week 3: RCI, 61%; placebo, 49%
DSS at week 4: RCI, 65%; placebo, 48%
Simsarian et al (2011)48
N=20
Age: 39.5
US
Intervention
RCI SC (n=10) vs RCI IM (both self-administered) (n=10)
Treatment duration
5 days
Assessments
Baseline, days 7 and 14
Mean EDSS scores at baseline: IM, 2.30; SC, 2.80; all, 2.55
Mean EDSS score on day 7±1 day: IM, 1.20; SC, 2.65; all, 1.93
Mean EDSS scores on day 14±1 day: IM, 1.10; SC, 2.89; all, 1.95

Abbreviations: DSS, Disability Status Scale; EDSS, Expanded Disability Status Scale; IM, intramuscular; NR, not reported; RCI, repository corticotropin injection; RCT, randomized controlled trial; SC, subcutaneous; US, United States.